Project Grant R44CA281709
Award Date
7/1/24
Completion Date
6/30/27
Dollars Obligated
$719K
Federal Agency
National Cancer Institute
Federal Grant Program
93.395
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This $800,000 Project Grant award by the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395) supports the development of a novel biologic therapy by Creative Biotherapeutics LLC to eradicate brain cancer and brain metastases. The grantee's research has identified a key extracellular protein, eGRP78, that is upregulated in drug-resistant brain tumors and drives tumor growth, immune evasion, and stem cell formation. Their lead inhibitor, CBT300, has...
The federal Project Grant award R01CA275767, funded by the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research), will support research to characterize synaptic density changes in the brain using quantitative positron emission tomography (PET) imaging after radiation therapy. The $1,474,236 award, with a project period from Sep 2024 to Aug 2028, will enable a research team from The Children's Hospital of Philadelphia and the University of Pennsylvania to: Establish...
This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) in the amount of $244,839 will fund research aimed at developing a novel, less invasive approach to treat pediatric brain cancers, specifically Group 3 medulloblastoma. The research will explore the use of magnetic resonance imaging-guided focused ultrasound (MRGFUS) to enhance the delivery and effectiveness of adoptive cellular immunotherapy (B7-H3-targeted CAR T cells) in...
This $603,206 Project Grant awarded by the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) supports the development and clinical evaluation of a software system to aid physicians performing microwave ablation of liver tumors. The software is designed to simulate the physics of the ablation procedure and highlight on CT images the tissues that have been killed, enabling physicians to more accurately determine if the entire tumor has been treated. The project involves a...
This Project Grant award of $639,642 from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) supports the development and validation of a non-invasive "Radiomics Spatial Map" (Rad-I Map) technology to identify the extent of infiltrating glioblastoma (GBM) tumor versus confounding pathologies like vasogenic edema and treatment effects on MRI scans. The key objectives are to: 1) Improve the initial Rad-I Map by incorporating additional MRI sequences and...
This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), aims to externally validate and integrate radio-pathomic models developed using autopsy and biopsy samples from the Medical College of Wisconsin (MCW) and the University of California, San Francisco (UCSF). The $677,998 award, with a project period from February 1, 2025 to January 31, 2030, will focus on three key objectives: Externally validate...
This $704,563 Project Grant awarded by the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) focuses on developing quantitative MRI (qMRI) tools and an automated prostate cancer tumor segmentation method to improve identification of clinically significant prostate tumors for radiation therapy treatment planning. The project aims to build a qMRI toolset including magnetic resonance fingerprinting, arterial spin labeling, and diffusion-weighted MRI to generate 3D...
This Project Grant award for $616,710.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports the Children's Research Institute in Washington, D.C. in designing effective adoptive immunotherapy for high-risk pediatric medulloblastoma. The research aims to develop a rational combination with MRI-guided focused ultrasound technology to enhance this innovative cancer treatment approach. The award period runs from August 1, 2024...
This Project Grant award of $2,278,167.00 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), supports the development of non-invasive transcranial volumetric super-resolution imaging, targeted contrast agents, and image-guided focused ultrasound surgery technologies. The award aims to address key challenges in identifying tumor boundaries, targeting...
This federal Project Grant award of $857,315.00 from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) supports a randomized controlled clinical study comparing two Convection Enhanced Delivery (CED) catheter systems for delivering therapeutics to recurrent grade 3-4 glioma (brain tumor) patients. The primary innovations under this award include: Evaluating the safety and enhanced therapeutic coverage of a novel Porous Brain Infusion Catheter (PBIC) system, which utilizes...